Prescribing outside of a drug’s licence: issues and implications

The GMC recently published updated guidance on prescribing outside of a medication’s licence. Here, we examine the drivers and implications for off-label prescribing, with a particular focus on the issues surrounding the prescribing of bevacizumab in wet AMD.

Prescribing outside of a drugs licence issues and implications

Add yours ↓
Web design and marketing agency Leamington Spa